Enhanced anti-tumor responses induced by the combination of a couple of stimulators: IL-12 and CCL27

被引:0
|
作者
Sugita, T
Gao, JQ
Kanagawa, N
Motomura, Y
Nakayama, T
Yoshie, O
Hatanaka, Y
Tani, Y
Mizuguchi, H
Tsutsumi, Y
Nakagawa, S
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan
[2] Kinki Univ, Sch Med, Dept Microbiol, Osaka 589, Japan
[3] DakoCytomat Co Ltd, Dept Biomed Sci, Kyoto, Japan
[4] Natl Inst Biomed Innovat, Osaka, Japan
来源
JOURNAL OF GENE MEDICINE | 2006年 / 8卷 / 03期
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:397 / 397
页数:1
相关论文
共 50 条
  • [1] NK cells are migrated and indispensable in the anti-tumor activity induced by CCL27 gene therapy
    Jian-Qing Gao
    Yasuhiro Tsuda
    Min Han
    Dong-Hang Xu
    Naoko Kanagawa
    Yutaka Hatanaka
    Yoichi Tani
    Hiroyuki Mizuguchi
    Yasuo Tsutsumi
    Tadanori Mayumi
    Naoki Okada
    Shinsaku Nakagawa
    Cancer Immunology, Immunotherapy, 2009, 58
  • [2] NK cells are migrated and indispensable in the anti-tumor activity induced by CCL27 gene therapy
    Gao, Jian-Qing
    Tsuda, Yasuhiro
    Han, Min
    Xu, Dong-Hang
    Kanagawa, Naoko
    Hatanaka, Yutaka
    Tani, Yoichi
    Mizuguchi, Hiroyuki
    Tsutsumi, Yasuo
    Mayumi, Tadanori
    Okada, Naoki
    Nakagawa, Shinsaku
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (02) : 291 - 299
  • [3] Gene therapy with IL-12 induced enhanced anti-tumor activity in fibrosarcoma mouse model
    Soofiyani, Saiedeh Razi
    Kazemi, Tohid
    Lotfipour, Farzaneh
    Hosseini, Akbar Mohammad
    Shanehbandi, Dariush
    Hallaj-Nezhadi, Somayeh
    Baradaran, Behzad
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2016, 44 (08) : 1988 - 1993
  • [4] Combination of recombinant murine IL-12 and anti-PD-1 induced synergistic anti-tumor response.
    Tsou, Peiyi
    Lin, Wan-Ying
    Lee, Meng-Na
    Chen, San-Chi
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer
    Gao, J-Q
    Kanagawa, N.
    Motomura, Y.
    Yanagawa, T.
    Sugita, T.
    Hatanaka, Y.
    Tani, Y.
    Mizuguchi, H.
    Tsutsumi, Y.
    Mayumi, T.
    Okada, N.
    Nakagawa, S.
    GENE THERAPY, 2007, 14 (06) : 491 - 502
  • [6] Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer
    J-Q Gao
    N Kanagawa
    Y Motomura
    T Yanagawa
    T Sugita
    Y Hatanaka
    Y Tani
    H Mizuguchi
    Y Tsutsumi
    T Mayumi
    N Okada
    S Nakagawa
    Gene Therapy, 2007, 14 : 491 - 502
  • [7] Anti-Tumor Effect of Tumor Specific Replicating Adenovirus Expressing IL-12 and IL-18
    Huang, Jing-Hua
    Choi, Il-Kyu
    Jung, Sung-Mi
    Kim, Minjung
    Sohn, Joo-Hyuk
    Yun, Chae-Ok
    Kim, Joo-Hang
    MOLECULAR THERAPY, 2006, 13 : S325 - S325
  • [8] Synergistic anti-tumor effect of glycosylphosphatidylinositol-anchored IL-2 and IL-12
    Ji, JF
    Li, JH
    Holmes, LM
    Burgin, KE
    Yu, XZ
    Wagner, TE
    Wei, YZ
    JOURNAL OF GENE MEDICINE, 2004, 6 (07): : 777 - 785
  • [9] WTX-330, a conditionally activated IL-12 INDUKINE, releases IL-12 selectively in the tumor microenvironment to activate anti-tumor immune responses and induce regressions in mouse tumor models.
    Steiner, Philipp
    Brodkin, Heather
    Hicklin, Dan
    Ismail, Nesreen
    Morris, Kristin
    Nirschl, Christopher
    Salmeron, Andres
    Seidel-Dugan, Cindy
    Steuert, Zoe
    Sullivan, Jenna
    Winston, William
    CANCER RESEARCH, 2021, 81 (13)
  • [10] Recombination plasmid carrying hcg and survivin combination IL-12 generates specific immune responses and anti-tumor effects in a murine breast carcinoma model
    Wang, Lei
    Liu, Ying
    Huo, Jingrui
    Liu, Yuanyuan
    Tian, Yi
    Yang, Xiaohui
    Zhang, Jingjing
    Liu, Yingfu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (07): : 10676 - 10682